Jill Glasspool-Malone

Jill Glasspool-Malone is an American biotechnology researcher and entrepreneur. She is married to Robert Malone.

Glasspool-Malone studied anthropology at the University of California San Diego from September 1986 - June 1989, with an emphasis on behaviour.¹⁾ She then studied Comparative Pathology at the University of California Davis from September 1994 - December 1996.

In January 1997, she started work as a research specialist at the University of Baltimore, acting as a Biosecurity Level 2 (BSL-2) laboratory manager and supervisor. Her duties included managing the lab's regulatory needs, budgeting, grant writing, and writing papers for publication on the topics of immunology, cell culture, gene transfer, and genetic vaccination. She remained in this position until August 2000.

Glasspool-Malone co-founded Intradigm, a gene therapy and targeted drug delivery company in Rockville, Maryland. She began working on the startup in August 1999 as Managing Director, helping to secure $2.3 million in venture capital funding, setting up laboratory and office facilities, and developing the company's scientific and business development plan.²⁾ Intradigm launched in mid-2000.³⁾

On April 19, 2001, Glasspool-Malone founded the Gene Delivery Alliance.⁴⁾ In 2002, she published a paper titled Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields with Robert Malone on which she lists Gene Delivery Alliance as her affiliation.⁵⁾

She and Robert both received postgraduate training as a Harvard Medical School Global Clinical Scholar in 2015-2016.⁶⁾

On May 17, 2021, Glasspool-Malone posted two back-to-back comments on an IPWatchdog article titled “The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I”. The first comment read, “Robert Malone and I have a patent that included RNA vaccination, which expired in 2017, but it is interesting because many of the patents listed above and issued prior to 2017 – claim nasal and mucosal routes.” She included the patent, titled “DNA vaccines for eliciting a mucosal immune response”. The second comment, posted only four minutes later, read, “As Robert Malone clearly invented mRNA vaccines while at the Salk and Vical, it is interesting that there is not mention of his work?” followed by a series of publications and patents.⁷⁾

• Electroporative delivery of molecules to organs
• May 24, 1996: DNA vaccines for eliciting a mucosal immune response

• March 28, 2002: DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor

• Housatonic